Miller Joseph M
CIK 0001746372
Chief Financial OfficerDirector
Filings
11
Latest Mar 3, 2026
Issuers covered
2
Showing
11 of 11
Page 1
Track record
6 of 6 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 6 | 33% | -5.5% | -5.5% | +8.5% | -15.4% |
| 90 days | 6 | 67% | +1.5% | +0.9% | +4.5% | -0.2% |
| 180 days | 6 | 17% | -13.6% | -11.7% | +35.4% | -46.4% |
| 365 days | 6 | 50% | -19.7% | -12.7% | +35.3% | -86.1% |
Issuers
Companies where Miller Joseph M has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| AUPH | Aurinia Pharmaceuticals Inc. | 9 | Mar 3, 2026 |
| AVTX | Avalo Therapeutics, Inc. | 2 | Apr 4, 2022 |
All filings
11 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|